Summary
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The global Hyperimmune Globulins market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
CSL Behring
Grifols?
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Government Institutions
Private Sector
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Hyperimmune Globulins Picture
1.1.2 Specifications
Table Product Specifications of Hyperimmune Globulins
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Hyperimmune Globulins
Table Global Hyperimmune Globulins Market by Type, 2016-2026 (USD Million)
1.2.1.1 Hepatitis B Immunoglobulins
Table Hepatitis B Immunoglobulins Overview
1.2.1.2 Rabies Immunoglobulins
Table Rabies Immunoglobulins Overview
1.2.1.3 Tetanus Immunoglobulins
Table Tetanus Immunoglobulins Overview
1.2.1.4 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Hyperimmune Globulins
Table Global Hyperimmune Globulins Market by Application, 2016-2026 (USD Million)
1.2.2.1 Government Institutions
Table Government Institutions Overview
1.2.2.2 Private Sector
Table Private Sector Overview
1.2.2.3 Others
Table Others Overview
1.2.3 by Regions
Table Global Hyperimmune Globulins Market by Region, 2016-2026 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Hyperimmune Globulins
2.2 Upstream
Table Cost of Hyperimmune Globulins
Figure Manufacturing Process of Hyperimmune Globulins
2.3 Market
2.3.1 SWOT
Figure SWOT of Hyperimmune Globulins
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Hyperimmune Globulins
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Hyperimmune Globulins
3.4 Market Entry
Table Market Entry of Hyperimmune Globulins
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Hepatitis B Immunoglobulins Market, 2016-2020
Figure Hepatitis B Immunoglobulins Market Size and Growth, 2016-2020 (USD Million)
Figure Hepatitis B Immunoglobulins Market Size and Growth, 2016-2020 (in Volume)
Table Hepatitis B Immunoglobulins CAGR by Revenue and Volume, 2016-2020
4.1.2 Rabies Immunoglobulins Market, 2016-2020
Figure Rabies Immunoglobulins Market Size and Growth, 2016-2020 (USD Million)
Figure Rabies Immunoglobulins Market Size and Growth, 2016-2020 (in Volume)
Table Rabies Immunoglobulins CAGR by Revenue and Volume, 2016-2020
4.1.3 Tetanus Immunoglobulins Market, 2016-2020
Figure Tetanus Immunoglobulins Market Size and Growth, 2016-2020 (USD Million)
Figure Tetanus Immunoglobulins Market Size and Growth, 2016-2020 (in Volume)
Table Tetanus Immunoglobulins CAGR by Revenue and Volume, 2016-2020
4.1.4 Others Market, 2016-2020
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Others Market Size and Growth, 2016-2020 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2020
4.2 Market Forecast
4.2.1 Hepatitis B Immunoglobulins Market Forecast, 2021-2026
Figure Hepatitis B Immunoglobulins Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Hepatitis B Immunoglobulins Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Hepatitis B Immunoglobulins CAGR by Revenue and Volume, 2016-2026
4.2.2 Rabies Immunoglobulins Market Forecast, 2021-2026
Figure Rabies Immunoglobulins Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Rabies Immunoglobulins Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Rabies Immunoglobulins CAGR by Revenue and Volume, 2016-2026
4.2.3 Tetanus Immunoglobulins Market Forecast, 2021-2026
Figure Tetanus Immunoglobulins Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Tetanus Immunoglobulins Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Tetanus Immunoglobulins CAGR by Revenue and Volume, 2016-2026
4.2.4 Others Market Forecast, 2021-2026
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2026
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Government Institutions Market, 2016-2020
Figure Government Institutions Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Government Institutions CAGR by Revenue and Volume, 2016-2020
5.1.2 Private Sector Market, 2016-2020
Figure Private Sector Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Private Sector CAGR by Revenue and Volume, 2016-2020
5.1.3 Others Market, 2016-2020
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2020
5.2 Market Forecast
5.2.1 Government Institutions Market Forecast, 2021-2026
Figure Government Institutions Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Government Institutions Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Government Institutions CAGR by Revenue and Volume, 2021-2026
5.2.2 Private Sector Market Forecast, 2021-2026
Figure Private Sector Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Private Sector Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Private Sector CAGR by Revenue and Volume, 2021-2026
5.2.3 Others Market Forecast, 2021-2026
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Others CAGR by Revenue and Volume, 2021-2026
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2016-2020
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2016-2020
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Table North America CAGR by Revenue and Volume, 2016-2020
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2016-2020
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Table Europe CAGR by Revenue and Volume, 2016-2020
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2016-2020
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Table South America CAGR by Revenue and Volume, 2016-2020
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2016-2020
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2021-2026
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
6.2.2 North America Market Forecast, 2021-2026
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table North America CAGR by Revenue and Volume, 2021-2026
6.2.3 Europe Market Forecast, 2021-2026
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Europe CAGR by Revenue and Volume, 2021-2026
6.2.4 South America Market Forecast, 2021-2026
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table South America CAGR by Revenue and Volume, 2021-2026
6.2.5 Middle East & Africa Market Forecast, 2021-2026
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026
7 Market Competitive
7.1 Global Market by Vendors
Table Global Hyperimmune Globulins Market by Vendors, 2016-2020 (in Volume)
Table Global Hyperimmune Globulins Market Share by Vendors, 2016-2020 (USD Million)
Table Global Hyperimmune Globulins Market Share by Vendors, 2016-2020 (in Volume)
7.2 Market Concentration
Figure Hyperimmune Globulins Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 CSL Behring
Table CSL Behring Profile List
Table Microecological Modulator Operating Data of CSL Behring (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Grifols